��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Cost Effectiveness of Multiple Sclerosis Therapeutic Strategies for Achieving No Evidence of Disease Activity

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 193

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Daniel Ontaneda, MD, PhD, FAAN (Cleveland Clinic) PRESENTER	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
	No disclosure on file